Falsetti Irene, Palmini Gaia, Iantomasi Teresa, Brandi Maria Luisa, Tonelli Francesco
Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50139 Florence, Italy.
Fondazione Italiana Ricerca sulle Malattie dell'Osso (FIRMO Onlus), 50129 Florence, Italy.
Pharmaceutics. 2024 May 10;16(5):640. doi: 10.3390/pharmaceutics16050640.
Familial adenomatous polyposis (FAP) is a rare disease characterized by the development of adenomatous polyps in the colon and rectum already in adolescence. If left untreated, patients develop colorectal cancer (CRC) with a 100% probability. To date, the gold standard of FAP management is surgery, which is associated with morbidity and mortality. A chemopreventive agent capable of delaying, preventing and reversing the development of CRC has been sought. Several classes of drugs have been used but to date no chemopreventive drug has been found for the management of this disease. In recent years, the importance of estrogen receptors in FAP and CRC, particularly the β subtype, has emerged. Indeed, the expression of the latter is strongly reduced in adenomatous polyps and CRC and is inversely correlated with the aggressiveness of the disease. Since phytoestrogens have a high affinity for this receptor, they have been suggested for use as chemopreventive agents in FAP and CRC. A combination of phytoestrogens and insoluble fibres has proved particularly effective. In this review, the various mechanisms of action of phytoestrogens were analyzed and the effectiveness of using phytoestrogens as an effective chemopreventive strategy was discussed.
家族性腺瘤性息肉病(FAP)是一种罕见疾病,其特征是在青春期时结肠和直肠就会出现腺瘤性息肉。如果不进行治疗,患者患结直肠癌(CRC)的概率为100%。迄今为止,FAP治疗的金标准是手术,但手术存在发病率和死亡率。人们一直在寻找一种能够延缓、预防和逆转结直肠癌发展的化学预防剂。已经使用了几类药物,但迄今为止尚未找到用于治疗这种疾病的化学预防药物。近年来,雌激素受体在FAP和CRC中的重要性,特别是β亚型,已经显现出来。事实上,后者在腺瘤性息肉和CRC中的表达显著降低,并且与疾病的侵袭性呈负相关。由于植物雌激素对该受体具有高亲和力,因此有人建议将其用作FAP和CRC的化学预防剂。事实证明,植物雌激素和不溶性纤维的组合特别有效。在这篇综述中,分析了植物雌激素的各种作用机制,并讨论了将植物雌激素用作有效化学预防策略的有效性。